Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain

被引:144
|
作者
du Sert, N. Percie [1 ]
Rice, A. S. C. [2 ,3 ]
机构
[1] Natl Ctr Replacement Refinement & Reduct Anim Res, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England
[3] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
关键词
animal model; translation; neuropathic pain; analgesic; preclinical model; PERIPHERAL-NERVE INJURY; IN-VIVO EXPERIMENTS; POSTHERPETIC NEURALGIA; RODENT MODELS; RAT MODEL; PHARMACOLOGICAL MANAGEMENT; PREDICTIVE-VALIDITY; BURROWING BEHAVIOR; GRIMACE SCALE; GABAPENTIN;
D O I
10.1111/bph.12645
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuropathic pain remains an area of considerable unmet clinical need. Research based on preclinical animal models has failed to deliver truly novel treatment options, questioning the predictive value of these models. This review addresses the shortcomings of rodent in vivo models commonly used in the field and highlights approaches which could increase their predictivity, including more clinically relevant assays, outcome measures and animal characteristics. The methodological quality of animal studies also needs to be improved. Low internal validity and incomplete reporting lead to a waste of valuable research resources and animal lives, and ultimately prevent an objective assessment of the true predictivity of in vivo models.
引用
收藏
页码:2951 / 2963
页数:13
相关论文
共 50 条
  • [21] The broad analgesic profile of lacosamide in animal models of pain
    Freitag, J.
    Beyreuther, B.
    Stoehr, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 137 - 137
  • [22] Animal models of tauopathies and their implications for research/translation into the clinic
    Dujardin, S.
    Colin, M.
    Buee, L.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (01) : 59 - 80
  • [23] Improving translation of animal models of addiction and relapse by reverse translation
    Venniro, Marco
    Banks, Matthew L.
    Heilig, Markus
    Epstein, David H.
    Shaham, Yavin
    NATURE REVIEWS NEUROSCIENCE, 2020, 21 (11) : 625 - 643
  • [24] Improving translation of animal models of addiction and relapse by reverse translation
    Marco Venniro
    Matthew L. Banks
    Markus Heilig
    David H. Epstein
    Yavin Shaham
    Nature Reviews Neuroscience, 2020, 21 : 625 - 643
  • [25] Experimental and clinical pain models in the pharmacology of analgesic drugs
    Lotsch, J
    Kobal, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : S17 - S17
  • [26] Coping with neuropathic pain: Do we need more selective analgesic drugs?
    Mattia, C
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (23) : 2941 - 2943
  • [27] Drugs for neuropathic pain
    Kalso, Eija
    Aldington, D. J.
    Moore, R. A.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [28] Cytokine regulation in animal models of neuropathic pain and in human diseases
    Ueceyler, Nurcan
    Sommer, Claudia
    NEUROSCIENCE LETTERS, 2008, 437 (03) : 194 - 198
  • [29] Further evidences of the efficacy of agomelatine in animal models of neuropathic pain
    Mocaer, E.
    Chenaf, C.
    Lolignier, S.
    Chapuy, E.
    Bertrand, M.
    Gabriel, C.
    Eschalier, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S268 - S269
  • [30] Antiepileptics and the treatment of neuropathic pain: Evidence from animal models
    Blackburn-Munro, G
    Erichsen, HK
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (23) : 2961 - 2976